The genus Bacillus has been in use in the biotechnology industry for a very long time with a number of new cultures exhibiting a variety of benefits to humans. The present study focuses on phenotypic and genotypic characterization of a probiotic lactic acid bacteria, Bacillus coagulans (IS-2 a Unique-Biotech strain) isolated from human feces and contaminated soils. Probiotics are live microbes ...

Microbial strains with high substrate efficiency and excellent environmental tolerance are urgently needed for the production of platform bio-chemicals. Bacillus coagulans has these merits; however, little genetic information is available about this species. Here, we determined the genome sequences of five B. coagulans strains, and used a comparative genomic approach to reconstruct the central ...

Previous investigations have revealed that Bacillus coagulans strain 43P is sensitive to the polypeptide antibiotic nisin (O'Brien et al., 1956; Campbell and Sniff, 1959; Campbell, Sniff, and O'Brien, 1959). It has also been found that nisin is effective in the control of the flat sour spoilage of tomato juice in inoculated pack studies with this strain of B. coagulans (Campbell et al., 1959). ...

Antifungal activity of Bacillus coagulans creates the possibility to use this microorganism in biological control of fungal plant pathogens. Activity of Bacillus coagulans (No 6), isolated from lupine compost, against seven pathogenic species of indicator fungi: Bipolaris sorokiniana, Trichothecium roseum, Rhizoctonia solani, Sclerotinia sclerotiorum, Fusatium oxysporum, Fusarium solani and Fus...

To our knowledge and literature search, Staphylococcus schleiferi subspecies coagulans infection in human beings has rarely been described in the medical literature. Furthermore, we believe that this is a first detailed case report of methicillin-resistant Staphylococcus schleiferi subspecies coagulans infection in a patient with hepatocellular carcinoma. Because of the possible association of ...